Pliant Therapeutics
PLRX
PLRX
88 hedge funds and large institutions have $416M invested in Pliant Therapeutics in 2021 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 13 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
19% less capital invested
Capital invested by funds: $512M → $416M (-$96M)
50% less call options, than puts
Call options by funds: $326K | Put options by funds: $655K
Holders
88
Holding in Top 10
3
Calls
$326K
Puts
$655K
Top Buyers
1 | +$15.3M | |
2 | +$5.22M | |
3 | +$3.69M | |
4 |
Morgan Stanley
New York
|
+$2.59M |
5 |
BlackRock
New York
|
+$1.83M |
Top Sellers
1 | -$28.9M | |
2 | -$3.04M | |
3 | -$2.7M | |
4 |
D.E. Shaw & Co
New York
|
-$357K |
5 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$201K |